deaths (OS)

mNSCLC - L2 - all population metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - all population

versus docetaxel
nivolumab alone vs. docetaxel 1 0.68 [0.52; 0.89], 1 RCT, I2=0% conclusive
unassessable degree of certainty